Ideal Medical Products Engineering

by Sharon O’Reilly With artificial discs experiencing a cooling trend due to an expected reduction in reimbursement for both cervical and lumbar disc replacement, the spotlight on spine arthroplasty a

Medtech Investing Secondary Buyers Offer Exit for BSX, Others Saints Capital’s decision to pay $100 million for 54 companies from Boston Scientific Corp .’s corporate venture profile is an obvious ou

A look at medical device and in vitro diagnostics/research financing, M&A, and alliance activity January–March 2008 In this issue, we present a review of medical device and in vitro diagnostics/rese

One of the hottest sectors for device investors over the past several years, artificial discs in spine are retrenching, due to reimbursement constraints and slower-than-expected adoption of the device